A method of use for cannabidiol in the prevention and treatment of interferon-responsive conditions

EP4504686A4Pending Publication Date: 2026-06-03AKSEERA PHARM CORP +3
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
AKSEERA PHARM CORP
Filing Date
2023-04-10
Publication Date
2026-06-03

Smart Images

  • Figure 00000080_0000
    Figure 00000080_0000
  • Figure 00000080_0001
    Figure 00000080_0001
  • Figure 00000081_0000
    Figure 00000081_0000
Patent Text Reader

Abstract

The invention relates to Cannabidiol or compositions of Cannabidiol for use in the treatment of infections caused by pathogens and parasites. The invention relates to use of Cannabidiol or compositions of Cannabidiol for the treatment of infections caused by pathogens, particularly those pathogens which are likely to activate either cGAS-STING pathway or 2',5'-oligoadenylate synthetase (OAS)-RNase L pathway. The invention relates to Cannabidiol or compositions of Cannabidiol for use in the prevention of infections / prophylaxis or priming animal or host for better preparing for infections.
Need to check novelty before this filing date? Find Prior Art